Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation

Journal of Clinical Oncology

Volumn 29, Issue 15, 2011, Pages 1980-1986

  Gratwohl, Alois ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Brand, Ronald ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Niederwieser, Dietger ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Baldomero, Helen ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Chabannon, Christian ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Cornelissen, Jan ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   De Witte, Theo ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Ljungman, Per ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   McDonald, Fiona ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   McGrath, Eoin ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Passweg, Jakob ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Peters, Christina ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Rocha, Vanderson ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Slaper Cortenbach, Ineke ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Sureda, Anna ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Tichelli, Andre ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Apperley, Jane ^{a,b,c,d,e,f,g,h,i,j,k,l,m}  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL   (Switzerland)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^h INSTITUT PAOLI CALMETTES   (France)

ⁱ SAINT LOUIS HOSPITAL   (France)

^j KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^k HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^l ST ANNA CHILDREN S HOSPITAL   (Austria)

^m HAMMERSMITH HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACCREDITATION; ACUTE LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER MORTALITY; CHILD; CHRONIC LEUKEMIA; CLINICAL ASSESSMENT; FEMALE; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCOME; JOINT ACCREDITATION COMMITTEE INTERNATIONAL SOCIETY FOR CELLULAR THERAPY AND THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL TIME; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME;

ACCREDITATION; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MIDDLE AGED; PATIENT CARE MANAGEMENT; QUALITY OF HEALTH CARE; TREATMENT OUTCOME;

EID: 79956294709     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.30.4121     Document Type: Article

References (35)

1. Thomas ED: A history of allogeneic hematopoietic cell transplantation, in Appelbaum FR, Forman S, Negrin RS, et al (eds): Thomas' Hematopoietic Cell Transplantation (ed 4). Oxford, United Kingdom, Wiley Blackwell, 2009, pp 3-7
2. Armitage JO: The history of autologous hematopoietic cell transplantation, in Appelbaum FR, Forman S, Negrin RS, et al (eds): Thomas' Hematopoietic Cell Transplantation (ed 4). Oxford, United Kingdom, Wiley Blackwell, 2009, pp 8-14
3. Copelan EA: Hematopoietic stem-cell transplantation. N Engl J Med 354:1813-1826, 2006
4. Appelbaum FR: Hematopoietic-cell transplantation at 50. N Engl J Med 357:1472-1475, 2007
5. Ljungman P, Bregni M, Brune M, et al: Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Current practice in Europe 2009. Bone Marrow Transplant 45: 219-234, 2010
6. Gratwohl A, Baldomero H, Aljurf M, et al: Hematopoietic stem cell transplantation: A global perspective. JAMA 303:1617-1624, 2010
7. Kvalheim G, Gratwohl A, Urbano-Ispizua A, et al: JACIE accreditation in Europe moves ahead. Cytotherapy 5:306-308, 2003 (Pubitemid 37264997)
8. Zahnd D, Leibundgut K, Zenhäusern R, et al: Implementation of the JACIE standards for a haematopoietic progenitor cell transplantation programme: A cost analysis. Bone Marrow Transplant 34:847-853, 2004 (Pubitemid 39562135)
9. Apperley J: Just another cost increasing exercise (JACIE)? Bone Marrow Transplant 34:835-838, 2004
10. Gratwohl A, Stern M, Brand R, et al: Risk score for outcome after allogeneic hematopoietic stem cell transplantation: A retrospective analysis. Cancer 115:4715-4726, 2009
11. Gratwohl A, Hermans J, Goldman JM, et al: Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation: Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 352:1087-1092, 1998 (Pubitemid 28448513)
12. Therneau TM, Grambsch PM (eds): Modeling Survival Data: Extending the Cox Model - Series Statistics for Biology and Health. Munich, Germany, Springer, 2000
13. Giebel S, Labopin M, Ehninger G, et al: Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemia. Blood 116: 122-128, 2010
14. Sorror ML, Sandmaier BM, Storer BE, et al: Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation. J Clin Oncol 25:4246-4254, 2007 (Pubitemid 47554249)
15. Ljungman P: Risk assessment in haematopoietic stem cell transplantation: Viral status. Best Pract Res Clin Haematol 20:209-217, 2007
16. Dickinson AM, Pearce KF, Norden J, et al: Impact of genomic risk factors on outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukemia. Haematologica 95: 922-927, 2010
17. Donot PE: JACIE: From guidelines to clinical practice and continuous quality improvement, the Léon-Bérard Cancer Center experience. Bull Cancer 96:797-804, 2009
18. Cornish JM: JACIE accreditation in paediatric haemopoietic SCT. Bone Marrow Transplant 42: S82-S86, 2008 (suppl 2)
19. Halle P, Roudeix D, Sozeau C, et al: Experiment of installation of a stepbase quality on the JACIE reference frame [in French]. Risques & Qualité 1:31-41, 2008
20. Ottinger H, Müller C, Beelen DW, et al: Developments and quality assurance in stem cell transplantation. Deutsches Ärzteblatt International 103: 2381-2386, 2006
21. Riet IV: Implementation of European quality standards (JACIE) for the programmes of Clerk's Office of Original Cells in Belgium [in French]. Onco 3:123-127, 2009
22. Rowley SD: Regulation of hematopoietic stem cell processing and transplantation. Int J Hematol 75:237-245, 2002
23. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use: Draft Consensus Guideline - Pharmaceutical Quality System Q10, May 9, 2007. http://www.fda.gov/downloads/ RegulatoryInformation/Guidances/ucm128031.pdf
24. Smith L, Lowdell MW: Quality issues in stem cell and immunotherapy laboratories. Transfus Med 13:417-423, 2003 (Pubitemid 37549039)
25. Arpagaus M, Leibundgut EO, Zbären K, et al: Real-time process/quality control for HPC processing. Cytotherapy 6:505-513, 2004 (Pubitemid 39433585)
26. Batalden P: "Quality improvement": Noun or verb? Qual Saf Health Care 11:152, 2002
27. Jones RB, Anasetti C, Appel P, et al: ASBMT committee report: White paper on measurement of quality outcomes. Biol Blood Marrow Transplant 12:594-597, 2006 (Pubitemid 43956369)
28. McKenna D Jr, Kadidlo D, Sumstad D, et al: Development and operation of a quality assurance system for deviations from standard operating procedures in a clinical cell therapy laboratory. Cyto-therapy 5:314-322, 2003 (Pubitemid 37264999)
29. LeMaistre CF, Loberiza FR Jr: What is quality in a transplant program? Biol Blood Marrow Transplant 11:241-246, 2005
30. Serke S, Johnsen HE: A European reference protocol for quality assessment and clinical validation of autologous haematopoietic blood progenitor and stem cell grafts. Bone Marrow Transplant 27:463-470, 2001 (Pubitemid 32266495)
31. Stahl JE, Vacanti JP, Gazelle S: Assessing emerging technologies: The case of organ replacement technologies - Volume, durability, cost. Int J Technol Assess Health Care 23:331-336,2007 (Pubitemid 46956890)
32. Haynes AB, Weiser TG, Berry WR, et al: A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med 360:491-499, 2009
33. Barkun JS, Aronson JK, Feldman LS, et al: Evaluation and stages of surgical innovations. Lancet 374:1089-1096, 2009
34. McCulloch P, Altman DG, Campbell WB, et al: No surgical innovation without evaluation: The IDEAL recommendations. Lancet 374:1105-1112, 2009
35. McNutt RA, Livingston EH: Evidence-based medicine requires appropriate clinical context. JAMA 303:454-455, 2010